Sacral Nerve Stimulation Devices Market Expected to Achieve 11.6% CAGR by 2029: Growth Forecast Insights

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Sacral Nerve Stimulation Devices Market Size By 2025?
The market for sacral nerve stimulation devices has seen a fast-paced growth in the latest years. The market value is projected to increase from $1.33 billion in 2024 to $1.49 billion in 2025, with a compound annual growth rate (CAGR) of 11.9%. Factors contributing to this growth during the historic period include the rising occurrence of urinary and fecal incontinence, technological improvements in neuromodulation, increased awareness of non-surgical therapies, beneficial reimbursement policies, the growth of the elderly population, a surge in neurological disorder cases, and augmented healthcare expenditures.

How Big Is the Sacral Nerve Stimulation Devices Market Size Expected to Grow by 2029?
The market for sacral nerve stimulation devices is set to experience swift expansion in the upcoming years. The market is projected to reach $2.31 billion by 2029, growing at a compound annual growth rate (CAGR) of 11.6%. The surge in the forecast period is credited to improved reimbursement policies, increased acceptance of neuromodulation therapies, the rising inclination for non-intrusive or minimally invasive procedures, investigations into sacral nerve stimulation devices, growing preference from both patients and healthcare providers, welcoming regulatory settings, and increasing global healthcare spending. The forecast period will see significant trends such as advancements in downsizing and implantable technologies, research into sacral nerve stimulation devices, the creation of external sacral nerve stimulation devices, enhanced patient education and cognizance, regulatory progress, market penetration, spinal cord stimulation, or peripheral nerve stimulation.

View the full report here:
https://www.thebusinessresearchcompany.com/report/sacral-nerve-stimulation-devices-global-market-report

Which Key Market Drivers Powering Sacral Nerve Stimulation Devices Market Expansion and Growth?
The growth of the sacral nerve stimulation devices market is predicted to be fueled by the rising occurrence of urological disorders. These disorders include a variety of conditions that can impact the urinary tract, kidneys, bladder, and prostate, and can range from acute to chronic disorders. Several factors can contribute to these disorders, including unhealthy dietary habits, dehydration, and lack of exercise, which can lead to kidney stones, a painful affliction of the urinary tract. Sacral nerve stimulation devices offer a minimally invasive solution that can effectively treat urological disorders such as urinary and fecal incontinence. As an example, in April 2024, the National Institute of Diabetes and Digestive and Kidney Diseases, a healthcare organization based in the US, stated that every year, on average, a total of 651,446 individuals 65 years and older (212,875 men and 438,572 women) were newly diagnosed with some form of urinary incontinence. Consequently, the growing incidence of urological disorders is projected to catalyze the expansion of the sacral nerve stimulation devices market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18458&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Sacral Nerve Stimulation Devices Market?
Innovation is a key focus for the main players in the sacral nerve stimulation devices market, with a particular emphasis on creating cutting-edge products such as advanced sacral neuromodulation devices. These next-generation tools are designed to stimulate sacral nerves more effectively, improving patient results, device effectiveness, and minimizing negative side effects. For example, Medtronic plc, a medical device company based in Ireland, introduced the InterStim X in February 2022. This next-generation device, specifically designed for sacral neuromodulation therapy, aims to help with the treatment of conditions like overactive bladder (OAB) and chronic fecal incontinence, as well as non-obstructive urinary retention. The InterStim X provides long-lasting, individualized treatment, eliminating the need for recharges. Its recharge-free design allows patients to benefit from over a decade of therapy, enhancing their convenience and adherence to treatment.

What Are the Emerging Segments in the Sacral Nerve Stimulation Devices Market?
The sacral nerve stimulation devices market covered in this report is segmented -

1) By Type: Electrical Muscle Stimulation, Transcutaneous Electrical Nerve Stimulation
2) By Product: External Sacral Nerve Stimulation (SNS) Devices, Implantable Sacral Nerve Stimulation (SNS) Devices
3) By Age: Pediatrics, Adults, Geriatrics
4) By Application: Urinary Incontinence, Fecal Incontinence, Other Applications
5) By End User: Hospital, Ambulatory Surgical Centers, Specialty Clinics

Subsegments:
1) By Electrical Muscle Stimulation: Surface Electrical Muscle Stimulation, Implantable Electrical Muscle Stimulation
2) By Transcutaneous Electrical Nerve Stimulation: Conventional TENS, Burst Mode TENS, Modulated TENS

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=18458&type=smp

Who Are the Global Leaders in the Sacral Nerve Stimulation Devices Market?
Major companies operating in the sacral nerve stimulation devices market are Abbott, Medtronic plc, Boston Scientific Corporation, Livanova, Axonics Modulation Technologies, Laborie Medical Technologies, Beijing PINS Medical Co. Ltd., Nevro Corp., Cala Health, Micro Systems Technologies, Neuspera Medical, EndoStim Inc., InCube Labs, Soterix Medical, Synapse Biomedical Inc, Soin Neuroscience, Nuvectra Corporation, StimGuard LLC, Medzell, General Stim Inc.

Which are the Top Profitable Regional Markets for the Sacral Nerve Stimulation Devices Industry?
North America was the largest region in the sacral nerve stimulation devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sacral nerve stimulation devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18458

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.